GastroenterologyCD276Pancreatic Cancer
CD276 Identified as Key Driver of Chemoresistance in Advanced Pancreatic Cancer
By MedXY|Apr 29, 2026
Single-cell analysis reveals CD276/B7-H3 as a critical regulator of chemoresistance in pancreatic ductal adenocarcinoma, highlighting its dual role in promoting basal-like tumor states and immune evasion.